İkbal Esen Aydıngöz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
İkbal Esen Aydıngöz has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Müjdat Uysal
Department of Biochemistry, Faculty of Medicine, Istanbul University, Istanbul, Turkey
2 shared publicationsPervin Vural
Department of Biochemistry, Faculty of Medicine, Istanbul University, Istanbul, Turkey
2 shared publicationsSemra Doğru-Abbasoğlu
Department of Biochemistry, Faculty of Medicine, Istanbul University, Istanbul, Turkey
2 shared publications- Şirin Yaşar
İSTANBUL HAYDARPAŞA NUMUNE SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ
2 shared publications A Fatih Aydin
Department of Biochemistry, Faculty of Medicine, Istanbul University, Istanbul, Turkey
1 shared publicationA. Gedikbaşi
Department of Biochemistry; Bakirköy Dr Sadi Konuk Research and Training Hospital; Istanbul Turkey
1 shared publication
Latest Publications
- Open Access
- 1 January 2017
- Published by Medknow in International Journal of Trichology
- Vol. 9 (4) , 171-176
Association of leukotrichia in vitiligo and Asp148Glu polymorphism of apurinic/apyrimidinic endonuclease 1
Background: Oxidative stress and increased DNA damage have been implicated in the etiopathogenesis of vitiligo. Oxidative DNA damage is mainly repaired by the base excision repair (BER) pathway. Aim: We sought to determine whether polymorphisms in DNA repair genes may have a role in the pathogenesis of vitiligo. Materials and Methods: We conducted a study including 100 patients with vitiligo and age- and sex-matched 193 control subjects to examine the role of single-nucleotide polymorphisms of BER genes, human 8-oxoG DNA N-glycosylase 1 (codon 326), apurinic/apyrimidinic endonuclease 1 (APE1) (codon 148), and X-ray repair cross-complementing group 1 (codon 399) as risk factors for vitiligo. These polymorphisms were determined by quantitative real-time polymerase chain reaction and melting curve analysis. Results: No significant association was observed between the variant alleles of studied genes and vitiligo. Conclusion: However, we showed that the presence of APE1 148Glu variant allele is associated with leukotrichia. This preliminary study suggests that APE1 (codon 148) polymorphism may play a role in vitiligo pathogenesis.
- 1 January 2017
- Published by Medknow in International Journal of Trichology
- Vol. 9 (4) , 171-176
Open AccessAssociation of leukotrichia in vitiligo and Asp148Glu polymorphism of apurinic/apyrimidinic endonuclease 1
Background: Oxidative stress and increased DNA damage have been implicated in the etiopathogenesis of vitiligo. Oxidative DNA damage is mainly repaired by the base excision repair (BER) pathway. Aim: We sought to determine whether polymorphisms in DNA repair genes may have a role in the pathogenesis of vitiligo. Materials and Methods: We conducted a study including 100 patients with vitiligo and age- and sex-matched 193 control subjects to examine the role of single-nucleotide polymorphisms of BER genes, human 8-oxoG DNA N-glycosylase 1 (codon 326), apurinic/apyrimidinic endonuclease 1 (APE1) (codon 148), and X-ray repair cross-complementing group 1 (codon 399) as risk factors for vitiligo. These polymorphisms were determined by quantitative real-time polymerase chain reaction and melting curve analysis. Results: No significant association was observed between the variant alleles of studied genes and vitiligo. Conclusion: However, we showed that the presence of APE1 148Glu variant allele is associated with leukotrichia. This preliminary study suggests that APE1 (codon 148) polymorphism may play a role in vitiligo pathogenesis.
- 4 October 2014
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 40 (1) , 71-77
The combination of tumour necrosis factor-α −308A and interleukin-10 −1082G gene polymorphisms and increased serum levels of related cytokines: susceptibility to vitiligo
The aetiopathogenesis of vitiligo is still under investigation. To assess the role of single nucleotide polymorphisms (SNPs) of the genes for tumour necrosis factor (TNF)-α, interleukin (IL)-6 and IL-10, as well as the serum levels of these three cytokines in the pathogenesis of vitiligo. The study enrolled 105 patients with vitiligo, and 211 age- and sex-matched controls. TNF-α (-308), IL-6 (-174) and IL-10 (-1082) promoter polymorphisms were investigated by LightSNiP assay and analysed by χ(2) test. Subsequently, the serum cytokine levels were assessed by ELISA and evaluated by Mann-Whitney U-test and Kruskal-Wallis test. The frequency of the GG genotype of the IL-10 -1082 polymorphism was significantly higher in the vitiligo group compared with the healthy control group (P = 0.02). Further investigations using combinations of these variant alleles detected a significant risk for vitiligo for individuals carrying both the IL-10 -1082G and TNF-α -308A alleles (OR = 12.57, 95% CI 1.44-110.0, P < 0.01). Serum IL-10 and TNF-α levels were higher in the vitiligo group (P = 0.001). In addition, TNF-α levels in patients with active disease were significantly higher than in patients with stable disease (P < 0.02). The concomitant presence of IL-10 -1082G and TNF-α -308A alleles significantly raises the risk for vitiligo. Furthermore, in accordance with these findings, serum IL-10 and TNF-α were also increased in this study, confirming the role of these cytokines in the pathogenesis of vitiligo.
- 4 October 2014
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 40 (1) , 71-77
The combination of tumour necrosis factor-α −308A and interleukin-10 −1082G gene polymorphisms and increased serum levels of related cytokines: susceptibility to vitiligo
The aetiopathogenesis of vitiligo is still under investigation. To assess the role of single nucleotide polymorphisms (SNPs) of the genes for tumour necrosis factor (TNF)-α, interleukin (IL)-6 and IL-10, as well as the serum levels of these three cytokines in the pathogenesis of vitiligo. The study enrolled 105 patients with vitiligo, and 211 age- and sex-matched controls. TNF-α (-308), IL-6 (-174) and IL-10 (-1082) promoter polymorphisms were investigated by LightSNiP assay and analysed by χ(2) test. Subsequently, the serum cytokine levels were assessed by ELISA and evaluated by Mann-Whitney U-test and Kruskal-Wallis test. The frequency of the GG genotype of the IL-10 -1082 polymorphism was significantly higher in the vitiligo group compared with the healthy control group (P = 0.02). Further investigations using combinations of these variant alleles detected a significant risk for vitiligo for individuals carrying both the IL-10 -1082G and TNF-α -308A alleles (OR = 12.57, 95% CI 1.44-110.0, P < 0.01). Serum IL-10 and TNF-α levels were higher in the vitiligo group (P = 0.001). In addition, TNF-α levels in patients with active disease were significantly higher than in patients with stable disease (P < 0.02). The concomitant presence of IL-10 -1082G and TNF-α -308A alleles significantly raises the risk for vitiligo. Furthermore, in accordance with these findings, serum IL-10 and TNF-α were also increased in this study, confirming the role of these cytokines in the pathogenesis of vitiligo.
- 16 July 2012
- Published by Wiley in International Journal of Dermatology
- Vol. 52 (7) , 840-842
Annular lichen planus-like keratosis: clues to pre-existing porokeratosis
- 16 July 2012
- Published by Wiley in International Journal of Dermatology
- Vol. 52 (7) , 840-842
Annular lichen planus-like keratosis: clues to pre-existing porokeratosis
- 26 June 2012
- Published by S. Karger AG in Dermatology
- Vol. 224 (4) , 361-368
Analysis of Vitamin D Receptor Gene Polymorphisms in Vitiligo
Background: Vitiligo is a progressive depigmenting disorder characterized by the loss of functional melanocytes from the epidermis. The etiopathogenesis of vitiligo is still unclear. Vitamin D has both stimulatory and protective effects on melanocytes and acts through its nuclear vitamin D receptor (VDR) on target cells. Aim: The aim of this study was to investigate the association between VDR gene polymorphisms and susceptibility to vitiligo. Methods: 98 patients with vitiligo and 216 age- and sex-matched controls recruited from dermatology outpatients attending the same department were included in the study. Genomic DNA was extracted from peripheral blood leukocytes using a DNA isolation kit. The VDR polymorphisms of BsmI, ApaI, TaqI, FokI and Cdx2 were investigated by rapid capillary PCR with melting curve analysis. Differences in genotype distributions and allele frequencies in vitiligo cases versus controls were compared for statistical significance using χ2 test. Results: Subjects with TaqI polymorphism had a 2.23-fold increased risk of developing vitiligo. Furthermore, a haplotype analysis showed that BsmI/ApaI/TaqI/FokI/Cdx2 GCCCG was significantly overrepresented in the vitiligo patients in comparison with controls (p = 0.031). Conclusion: This study showed that VDR TaqI gene polymorphism and the haplotype BsmI/ApaI/ TaqI/FokI/Cdx2 GCCCG may be considered as novel risk factors in vitiligo.
- 26 June 2012
- Published by S. Karger AG in Dermatology
- Vol. 224 (4) , 361-368
Analysis of Vitamin D Receptor Gene Polymorphisms in Vitiligo
Background: Vitiligo is a progressive depigmenting disorder characterized by the loss of functional melanocytes from the epidermis. The etiopathogenesis of vitiligo is still unclear. Vitamin D has both stimulatory and protective effects on melanocytes and acts through its nuclear vitamin D receptor (VDR) on target cells. Aim: The aim of this study was to investigate the association between VDR gene polymorphisms and susceptibility to vitiligo. Methods: 98 patients with vitiligo and 216 age- and sex-matched controls recruited from dermatology outpatients attending the same department were included in the study. Genomic DNA was extracted from peripheral blood leukocytes using a DNA isolation kit. The VDR polymorphisms of BsmI, ApaI, TaqI, FokI and Cdx2 were investigated by rapid capillary PCR with melting curve analysis. Differences in genotype distributions and allele frequencies in vitiligo cases versus controls were compared for statistical significance using χ2 test. Results: Subjects with TaqI polymorphism had a 2.23-fold increased risk of developing vitiligo. Furthermore, a haplotype analysis showed that BsmI/ApaI/TaqI/FokI/Cdx2 GCCCG was significantly overrepresented in the vitiligo patients in comparison with controls (p = 0.031). Conclusion: This study showed that VDR TaqI gene polymorphism and the haplotype BsmI/ApaI/ TaqI/FokI/Cdx2 GCCCG may be considered as novel risk factors in vitiligo.
- 1 December 2009
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 34 (8) , e802-e806
Composite haemangioendothelioma with lymph-node metastasis: an unusual presentation at an uncommon site
A 48-year-old woman presented with red papules on the thigh. Histopathological examination indicated pyogenic granuloma, and the patient was treated with total excision in 2003 and electrocauterization in 2005. Three months later, upon recurrence of the lesions, a diagnosis of composite haemangioendothelioma (CHE) was made. The patient was treated by total excision and lymph-node dissection, which revealed inguinal lymph-node metastasis. Despite the surgery, a further local recurrence occurred, subsequently treated by wide excision en bloc, with adjuvant radiotherapy and chemotherapy. Although CHE is defined as a vascular tumour with low-grade malignancy, the local recurrences and lymph-node metastases resulted in treatment difficulties in this case. Unlike earlier cases, the tumour in our patient presented as localized numerous small papulonodules, and lymph-node metastasis was detected within a relatively short time. Dermatologists and pathologists should be aware of this rare condition and include it in the differential diagnosis of vascular lesions.
- 1 December 2009
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 34 (8) , e802-e806
Composite haemangioendothelioma with lymph-node metastasis: an unusual presentation at an uncommon site
A 48-year-old woman presented with red papules on the thigh. Histopathological examination indicated pyogenic granuloma, and the patient was treated with total excision in 2003 and electrocauterization in 2005. Three months later, upon recurrence of the lesions, a diagnosis of composite haemangioendothelioma (CHE) was made. The patient was treated by total excision and lymph-node dissection, which revealed inguinal lymph-node metastasis. Despite the surgery, a further local recurrence occurred, subsequently treated by wide excision en bloc, with adjuvant radiotherapy and chemotherapy. Although CHE is defined as a vascular tumour with low-grade malignancy, the local recurrences and lymph-node metastases resulted in treatment difficulties in this case. Unlike earlier cases, the tumour in our patient presented as localized numerous small papulonodules, and lymph-node metastasis was detected within a relatively short time. Dermatologists and pathologists should be aware of this rare condition and include it in the differential diagnosis of vascular lesions.
- 22 May 2007
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 48 (2) , 102-104
Iododerma following sitz bath with povidone‐iodine
SUMMARY: A 50‐year‐old man developed numerous pustules and bullae on the trunk and limbs 15 days after anal fissure surgery. The clinicopathological diagnosis was iododerma induced by topical povidone‐iodine sitz baths postoperatively. Complete resolution occurred within 3 weeks using systemic corticosteroids and forced diuresis.
- 22 May 2007
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 48 (2) , 102-104
Iododerma following sitz bath with povidone‐iodine
SUMMARY: A 50‐year‐old man developed numerous pustules and bullae on the trunk and limbs 15 days after anal fissure surgery. The clinicopathological diagnosis was iododerma induced by topical povidone‐iodine sitz baths postoperatively. Complete resolution occurred within 3 weeks using systemic corticosteroids and forced diuresis.
- 12 May 2006
- Published by Wiley in The Journal of Dermatology
- Vol. 33 (5) , 360-363
Conjunctival squamous cell carcinoma in a patient with hemodialysis‐related porphyria cutanea tarda
Hemodialysis‐related porphyria cutanea tarda (HRPCT) is characterized by porphyria‐like blisters on sun‐exposed parts of the face, arms and hands due to elevated porphyrin levels. Conjunctival squamous cell carcinoma (CSCC) is a rare cancer that typically occurs on the sun‐damaged ocular surface of elderly male patients. Herein, we report a case of CSCC in a 72‐year‐old patient who had been on hemodialysis for 8 years, and had been followed up with a diagnosis of HRPCT for 3 years. To our knowledge, this is the first case report documenting an association between HRPCT and CSCC, which may reflect a pathogenetic process connecting them.
- 12 May 2006
- Published by Wiley in The Journal of Dermatology
- Vol. 33 (5) , 360-363
Conjunctival squamous cell carcinoma in a patient with hemodialysis‐related porphyria cutanea tarda
Hemodialysis‐related porphyria cutanea tarda (HRPCT) is characterized by porphyria‐like blisters on sun‐exposed parts of the face, arms and hands due to elevated porphyrin levels. Conjunctival squamous cell carcinoma (CSCC) is a rare cancer that typically occurs on the sun‐damaged ocular surface of elderly male patients. Herein, we report a case of CSCC in a 72‐year‐old patient who had been on hemodialysis for 8 years, and had been followed up with a diagnosis of HRPCT for 3 years. To our knowledge, this is the first case report documenting an association between HRPCT and CSCC, which may reflect a pathogenetic process connecting them.